Polistudium’s Post

The purpose of this study was to report clinical experience of a video-guided spirometry system in applying deep inhalation breath-hold (DIBH) radiotherapy for left-sided breast cancer, and to study the systematic and random uncertainties, intra- and interfraction motion and impact on cardiac dose associated with DIBH. Read it here 👉 https://lnkd.in/erMeyRgV . . . #SDXSystem #DIBH #Radiotherapy #BreastCancer #RadiationTherapy

💫 #ONCOnews 💫 🌟 Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial 👉 There was no difference in overall survival between the two groups (median 18·7 years [95% CI 16·5–21·5] in the no radiotherapy group vs 19·2 years [16·9–21·3] in the radiotherapy group; HR 1·08 [95% CI 0·89–1 ·30], log-rank p=0·43) 🔗 https://buff.ly/3WFyU3u #OncEd #OncoAlert

DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer. https://lnkd.in/eNBkqcHP

📌 Key Information About the European Society for Radiotherapy and Oncology (ESTRO) Learn how ESTRO is revolutionizing cancer care with innovative radiotherapy techniques, including proton therapy and AI-enhanced treatment planning. Dive into valuable insights from their congresses, research initiatives, and educational programs. For detailed info, visit: https://lnkd.in/euazdzsh #ESTRO24 #CancerCare #Radiotherapy #OncoDaily #Oncology #Cancer #Health #Medicine

Did you know? Compared with CT-guidance, MRI-guided #SBRT significantly reduced both moderate acute physician-scored toxic effects and decrements in patient-reported quality of life - in the recent MIRAGE Randomized Clinical Trial for #prostatecancer published in JAMA Oncology. Reference: 1. Kishan AU, Ma TM, Lamb JM et al. Magnetic resonance imaging-guided vs. computed tomography-guided stereotactic body radiotherapy for prostate cancer: The MIRAGE randomized clinical trial. JAMA Oncol. 2023; e1-e9.

Beyond complete remission: A comparatibe analysis of long-term laryngeal function in patients with hypopharyngeal and laryngeal cancer following radiotherapy and concurrent chemoradiation. https://lnkd.in/eAMYncae

Long-term evaluation of the safety of a rectal-prostate spacer, the ProSpace® balloon, in patients treated with radiotherapy for prostate cancer https://lnkd.in/e8QTGinA 🧪 #CancerResearch #Pathophysiology #CancerPrevention #CancerDiagnosis #CancerTreatment #Cancer #Oncology

🚨Highlights from ESMO 2024! Dr Michael Saerens, medical oncologist at University Hospital Ghent, shares key findings from recent clinical trials in head & neck cancer, including: - Weekly cisplatin shows non-inferiority with fewer side effects in SCCHN. - GORTEC REACH trial shows no added benefit of avelumab, cetuximab, and radiotherapy. - Setanaxib combined with pembrolizumab offers improved survival in recurrent/metastatic SCCHN. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #Oncology #HeadAndNeckCancer #ClinicalTrials #Immunotherapy

actrec classes on RT planning techniques, clinical radiotherapy, breast cancer, role of imaging, GU cancers, hematolymphoid malignancies, RT for bone and extremity tumours held on 20th April, 2024.

💫 #ONCOnews 💫 🌟 Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial 👉 This is the first phase III trial comparing SCRT followed by immunochemotherapy to LCRT followed by chemotherapy in LARC 🔗 https://buff.ly/4cIXEyk #OncEd #OncoAlert